Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report06 July 2022
We welcome the European Parliament’s decision to support the Taxonomy Complementary Climate Delegated Act (CDA) on climate change mitigation and adaptation covering certain gas and nuclear activities.
The adoption of this CDA is a hugely important milestone with the political landscape dominated by energy security challenges and the need to decarbonise global economies. Nuclear power can and should play an important role in the clean energy transition and the Parliament’s support for nuclear in the EU taxonomy supports energy sustainability, affordability, and security.
The Parliament’s decision now also puts the European nuclear industry on an equal footing with other parts of the world. The US, Canada, UK, China and many others are providing strong political and financial support to their nuclear industry and it is important that the EU demonstrates a similar approach.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries